Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011
24 Octubre 2011 - 8:00AM
Marketwired
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic
device company, today announced that it will release third quarter
2011 financial results before the market opens on Thursday,
November 10, 2011. The earnings release will be available on
Syneron's website at www.syneron.com.
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same day. A question & answer
session will follow management's discussion of events in the third
quarter 2011.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll free): (877) 844-6886 International: (970) 315-0315
The conference passcode for both is 21373962.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Overview page
on Syneron's website at www.syneron.com. Please log-in at least 10
minutes prior to the conference call in order to download the
applicable audio software. Following the conclusion of the call, a
replay of the webcast will be available within 24 hours on the
Company's website.
About Syneron Medical Ltd. Syneron Medical
Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company
with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The Company markets and services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide.
Contacts: Asaf Alperovitz Chief Financial Officer + 972
73 244 2283 Email: Email Contact Zack Kubow The Ruth Group
646-536-7020 Email: Email Contact
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024